Is Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Yahoo FinanceApr 17 19:57 ET
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
Yahoo FinanceMar 28 04:25 ET
Malibu Shines a Light on CLINUVEL's Pioneering Work in Photomedicine
Yahoo FinanceMar 4 21:38 ET
Clinuvel Pharmaceuticals GAAP EPS of A$0.22, Revenue of A$32.25B
Seeking AlphaFeb 23 10:16 ET
Earnings Call Summary | CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV(CLVLY.US) Q2 2023 Earnings Conference
The following is a summary of the Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2023 Earnings Call Transcript:Financial Performance:Clinuvel Pharmaceuticals reported a 15% increase in total revenue and
moomoo AIFeb 23 07:09 ET · Conference Call
CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV To Go Ex-Dividend On September 7th, 2023 With 0.03211 USD Dividend Per Share
August 31st - $CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV(CLVLY.US)$ is trading ex-dividend on September 7th, 2023. Shareholders of record on September 8th, 2023 will receive 0.03211 U
moomoo NewsAug 30, 2023 19:40 ET
CLINUVEL Trial Results Show Drug Reduces DNA Damage
Results in "children of the moon" disorder have implications for populations at highest risk of skin cancerMELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a
GlobeNewswireJan 15, 2023 18:25 ET
Clinuvel Pharmaceuticals reports 1H results
Clinuvel Pharmaceuticals (OTCPK:CLVLY) press release: 1H GAAP EPS of A$11.90c.Revenue of A$24.63M (+56.5% Y/Y).
Seeking AlphaFeb 23, 2022 09:24 ET
No Data
No Data